French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
The Diagast company has informed the users of the DuoLys reagent of the withdrawal of a lot. The users concerned, in France, have received the attached mail (20/09/2012) (24 KB). This information is intended for directors of health establishments, medical biologists and local correspondents of reactive vigilance for diffusion to the services concerned.